1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Acute Cholecystitis Treatment Market
4. Executive Summary
5. Voice of Customer
5.1.
Factors Contributing to Prevalence of Acute Cholecystitis
5.2.
Prevalence of Acute Cholecystitis, By Gender
5.3.
Prevalence of Acute Cholecystitis, By Age Group
5.4.
Preferred choice of Treatment for Acute Cholecystitis
6. Global Acute
Cholecystitis Treatment Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Type (Calculous Acute Cholecystitis v/s Acalculous
Acute Cholecystitis)
6.2.2.
By Cause (Gall Bladder Stones, Tumor, Bile Duct Blockage,
Microbial Infection, Others)
6.2.3.
By Diagnostic Procedure (Ultrasonography, Cholescintigraphy,
CT Scan, ERCP (Endoscopic Retrograde Cholangiopancreatography),
Others)
6.2.4.
By Treatment (Surgical v/s Non-Surgical)
6.2.5.
By End User (Hospitals & Clinics, Ambulatory Surgical
Centers, Others)
6.2.6.
By Company (2021)
6.2.7. By
Region
6.3.
Product Market Map
7. North America Acute
Cholecystitis Treatment Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Type
7.2.2.
By Cause
7.2.3.
By Diagnostic Procedure
7.2.4.
By Treatment
7.2.5.
By End User
7.2.6.
By Country
7.3.
North America: Country Analysis
7.3.1.
United States Acute Cholecystitis Treatment
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Cause
7.3.1.2.3.
By Diagnostic Procedure
7.3.1.2.4.
By Treatment
7.3.1.2.5.
By End User
7.3.2.
Mexico Acute Cholecystitis Treatment Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Cause
7.3.2.2.3.
By Diagnostic Procedure
7.3.2.2.4.
By Treatment
7.3.2.2.5.
By End User
7.3.3.
Canada Acute Cholecystitis Treatment Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Cause
7.3.3.2.3.
By Diagnostic Procedure
7.3.3.2.4.
By Treatment
7.3.3.2.5.
By End User
8. Europe Acute
Cholecystitis Treatment Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Type
8.2.2.
By Cause
8.2.3.
By Diagnostic Procedure
8.2.4.
By Treatment
8.2.5.
By End User
8.2.6.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Acute Cholecystitis Treatment Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Cause
8.3.1.2.3.
By Diagnostic Procedure
8.3.1.2.4.
By Treatment
8.3.1.2.5.
By End User
8.3.2.
Germany Acute Cholecystitis Treatment Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Cause
8.3.2.2.3.
By Diagnostic Procedure
8.3.2.2.4.
By Treatment
8.3.2.2.5.
By End User
8.3.3.
United Kingdom Acute Cholecystitis Treatment
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Cause
8.3.3.2.3.
By Diagnostic Procedure
8.3.3.2.4.
By Treatment
8.3.3.2.5.
By End User
8.3.4.
Italy Acute Cholecystitis Treatment Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Cause
8.3.4.2.3.
By Diagnostic Procedure
8.3.4.2.4.
By Treatment
8.3.4.2.5.
By End User
8.3.5.
Spain Acute Cholecystitis Treatment Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Cause
8.3.5.2.3.
By Diagnostic Procedure
8.3.5.2.4.
By Treatment
8.3.5.2.5.
By End User
8.3.6.
Sweden Acute Cholecystitis Treatment Market Outlook
8.3.6.1.
Market Size & Forecast
8.3.6.1.1.
By Value
8.3.6.2.
Market Share & Forecast
8.3.6.2.1.
By Type
8.3.6.2.2.
By Cause
8.3.6.2.3.
By Diagnostic Procedure
8.3.6.2.4.
By Treatment
8.3.6.2.5.
By End User
9. Asia-Pacific Acute
Cholecystitis Treatment Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Type
9.2.2.
By Cause
9.2.3.
By Diagnostic Procedure
9.2.4.
By Treatment
9.2.5.
By End User
9.2.6.
By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1.
China Acute Cholecystitis Treatment Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Cause
9.3.1.2.3.
By Diagnostic Procedure
9.3.1.2.4.
By Treatment
9.3.1.2.5.
By End User
9.3.2.
India Acute Cholecystitis Treatment Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Cause
9.3.2.2.3.
By Diagnostic Procedure
9.3.2.2.4.
By Treatment
9.3.2.2.5.
By End User
9.3.3.
South Korea Acute Cholecystitis Treatment
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Cause
9.3.3.2.3.
By Diagnostic Procedure
9.3.3.2.4.
By Treatment
9.3.3.2.5.
By End User
9.3.4.
Japan Acute Cholecystitis Treatment Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Cause
9.3.4.2.3.
By Diagnostic Procedure
9.3.4.2.4.
By Treatment
9.3.4.2.5.
By End User
9.3.5.
Australia Acute Cholecystitis Treatment
Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Type
9.3.5.2.2.
By Cause
9.3.5.2.3.
By Diagnostic Procedure
9.3.5.2.4.
By Treatment
9.3.5.2.5.
By End User
9.3.6.
Thailand Acute Cholecystitis Treatment
Market Outlook
9.3.6.1.
Market Size & Forecast
9.3.6.1.1.
By Value
9.3.6.2.
Market Share & Forecast
9.3.6.2.1.
By Type
9.3.6.2.2.
By Cause
9.3.6.2.3.
By Diagnostic Procedure
9.3.6.2.4.
By Treatment
9.3.6.2.5.
By End User
9.3.7.
Bangladesh Cholecystitis Treatment Market Outlook
9.3.7.1.
Market Size & Forecast
9.3.7.1.1.
By Value
9.3.7.2.
Market Share & Forecast
9.3.7.2.1.
By Type
9.3.7.2.2.
By Cause
9.3.7.2.3.
By Diagnostic Procedure
9.3.7.2.4.
By Treatment
9.3.7.2.5.
By End User
10. South America Acute
Cholecystitis Treatment Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Type
10.2.2.
By Cause
10.2.3.
By Diagnostic Procedure
10.2.4.
By Treatment
10.2.5.
By End User
10.2.6.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Acute Cholecystitis Treatment Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Cause
10.3.1.2.3.
By Diagnostic Procedure
10.3.1.2.4.
By Treatment
10.3.1.2.5.
By End User
10.3.2.
Argentina Acute Cholecystitis Treatment
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Cause
10.3.2.2.3.
By Diagnostic Procedure
10.3.2.2.4.
By Treatment
10.3.2.2.5.
By End User
10.3.3.
Colombia Acute Cholecystitis Treatment
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Cause
10.3.3.2.3.
By Diagnostic Procedure
10.3.3.2.4.
By Treatment
10.3.3.2.5.
By End User
10.3.4.
Chile Acute Cholecystitis Treatment Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Cause
10.3.4.2.3.
By Diagnostic Procedure
10.3.4.2.4.
By Treatment
10.3.4.2.5.
By End User
11. Middle East and
Africa Acute Cholecystitis Treatment Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Type
11.2.2.
By Cause
11.2.3.
By Diagnostic Procedure
11.2.4.
By Treatment
11.2.5.
By End User
11.2.6.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Acute Cholecystitis Treatment
Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Type
11.3.1.2.2.
By Cause
11.3.1.2.3.
By Diagnostic Procedure
11.3.1.2.4.
By Treatment
11.3.1.2.5.
By End User
11.3.2.
Saudi Arabia Acute Cholecystitis Treatment
Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Type
11.3.2.2.2.
By Cause
11.3.2.2.3.
By Diagnostic Procedure
11.3.2.2.4.
By Treatment
11.3.2.2.5.
By End User
11.3.3.
UAE Acute Cholecystitis Treatment Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Type
11.3.3.2.2.
By Cause
11.3.3.2.3.
By Diagnostic Procedure
11.3.3.2.4.
By Treatment
11.3.3.2.5.
By End User
11.3.4.
Turkey Acute Cholecystitis Treatment Market Outlook
11.3.4.1.
Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2.
Market Share & Forecast
11.3.4.2.1.
By Type
11.3.4.2.2.
By Cause
11.3.4.2.3.
By Diagnostic Procedure
11.3.4.2.4.
By Treatment
11.3.4.2.5.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
Competition Outlook
14.2.
Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1.
Boston Scientific
Corporation
14.2.2.
Fresenius Kabi AG
14.2.3.
Pfizer Inc
14.2.4.
Teva Pharmaceutical
Industries Ltd.
14.2.5.
Glenmark
Pharmaceuticals Limited
14.2.6.
Merck & Co.,
Inc.
14.2.7.
Becton, Dickinson
and Company
14.2.8.
Simulab Corporation
14.2.9.
AbbVie, Inc.
14.2.10.
Fortimedix Surgical
BV
15.
Strategic
Recommendations